Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

KNIGHT KNOX DEVELOPMENT CORP. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2019 4 Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Bought 2,700 shares @ $1.9613, valued at $5.3k
09/06/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/30/2019 4 Kelly Steven (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 22,250 options to buy @ $1.99, valued at $44.3k
08/30/2019 4 EMANUELE ROBERT MARTIN (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 17,500 options to buy @ $1.99, valued at $34.8k
08/30/2019 4 Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 75,000 options to buy @ $1.99, valued at $149.3k
08/30/2019 4 Erbez Georgia (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 22,250 options to buy @ $1.99, valued at $44.3k
08/30/2019 4 Blayney Douglas (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 18,000 options to buy @ $1.99, valued at $35.8k
08/30/2019 4 MATSUI CONNIE (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 26,500 options to buy @ $1.99, valued at $52.7k
07/26/2019 S-3 Form S-3 - Registration statement under Securities Act of 1933:
07/15/2019 8-K Quarterly results
Docs: "Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update"
07/15/2019 10-Q Quarterly Report for the period ended May 31, 2019
06/25/2019 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...
Docs: "Certificate of Change to the Articles of Incorporation of Artelo Biosciences, Inc",
"Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to Nasdaq",
"Artelo Biosciences Announces Closing of $8.0 Million Public Offering and Partial Exercise and Closing of Over-Allotment Option"
06/24/2019 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
06/21/2019 3 EMANUELE ROBERT MARTIN (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 3 Erbez Georgia (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 3 Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 3 Kelly Steven (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 3 MATSUI CONNIE (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 3 O'Brien Peter Michael (10% Owner) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 3 Moss David J (10% Owner) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 3 Blayney Douglas (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
06/21/2019 CERT Form CERT -
06/21/2019 EFFECT Form EFFECT - Notice of Effectiveness:
06/20/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/10/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/04/2019 D Form D - Notice of Exempt Offering of Securities:
06/04/2019 D Form D - Notice of Exempt Offering of Securities:
05/31/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/29/2019 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/30/2019 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events
04/15/2019 10-Q Quarterly Report for the period ended February 28, 2019
04/01/2019 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/11/2019 SC 13G/A Alinga Capital LLC reports a 7.2% stake in Artelo Biosciences Inc.
01/14/2019 10-Q Quarterly Report for the period ended November 30, 2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy